Wnt/β-catenin signaling may be involved with the maturation, but not the differentiation, of insulin-producing cells

Biomedicine and Pharmacotherapy

Volumn 67, Issue 8, 2013, Pages 745-750

  Shi, Qiping ^a   Luo, Simin ^a   Jia, Haiying ^a   Feng, Lie ^a   Lu, Xiaohua ^a   Zhou, Lixin ^a   Cai, Jiye ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Human adipose derived stem cells; Insulin producing cells; Wnt catenin signaling

Indexed keywords

BETA CATENIN; CYCLIN D1; GLUCOKINASE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; LIGAND; TRANSCRIPTION FACTOR 7; TRANSCRIPTION FACTOR PDX 1; WNT PROTEIN;

ADIPOSE DERIVED STEM CELL; ADIPOSE TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL MATURATION; CELL RENEWAL; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INSULIN RELEASE; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

HUMAN ADIPOSE-DERIVED STEM CELLS; INSULIN-PRODUCING CELLS; WNT/Β-CATENIN SIGNALING;

ADIPOSE TISSUE; BETA CATENIN; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MICROSCOPY, CONFOCAL; REAL-TIME POLYMERASE CHAIN REACTION; STEM CELLS; WNT SIGNALING PATHWAY; WNT1 PROTEIN;

EID: 84887617189     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2013.04.002     Document Type: Article

References (32)

1. International textbook of diabetes mellitus 2004, John Wiley and Sons, Chichester (UK). 3rd ed. R.A. DeFronzo, E. Ferrannini, H. Keen, P. Zimmet (Eds.).
2. Von Herrath M., Sanda S., Herold K. Type 1 diabetes as a relapsing-remitting disease?. Nat Rev Immunol 2007, 7:988-994.
3. Scully T. Diabetes in numbers. Nature 2012, 485:S2-S3.
4. Lechner A., Yong-Guang Y., Blacken R.A., Wang L., Nolan A.L., Habener J.F. No evidence for significant transdifferentiation of bone marrow into pancreatic β-cells in vivo. Diabetes 2004, 53:616-623.
5. Lumelsky N., Blondel O., Laeng P., Velasco I., Ravin R., McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001, 292:1389-1394.
6. Peek A.B., Yin L., Ramiya V. Animal models to study adult stem cell derived, in vitro generated islet implantation. ILAR J 2004, 45(3):259-267.
7. Kania G., Blyszczuk P., Czyz J., Navarrete-Santos A., Wobus A.M. Differentiation of mouse embryonic stem cells into pancreatic and hepatic cells. Methods Enzymol 2003, 365:287-303.
8. Kahan B.W., Jacobson L.M., Hullett D.A., et al. Pancreatic precursors and differentiated islet cell types from murine embryonic stem cells. Diabetes 2003, 52:2016-2024.
9. Stoffel M., Vallier L., Pedersen R.A. Navigating the pathway from embryonic stem cells to beta cells. Semin Cell Dev Biol 2004, 15:327-336.
10. Blyszczuk P., Czyz J., Kania G., et al. Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc Natl Acad Sci U S A 2003, 100:998-1003.
11. Miyazaki S., Yamato E., Miyazaki J. Regulated expression of pdx-1 promotes in vitro differentiation of insulin-producing cells from embryonic stem cells. Diabetes 2004, 53:1030-1037.
12. Peifer M., Polakis P. Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus. Science 2000, 287:1606-1609.
13. Moon R.T., Brown J.D., Torres M. WNTs modulate cell fate and behavior during vertebrate development. Trends Genet 1997, 13:157-162.
14. Fujino T., Asaba H., Kang M.J., et al. Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proc Natl Acad Sci U S A 2003, 100:229-234.
15. Liu Z., Habener J.F. Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta-cell proliferation. J Biol Chem 2008, 283:8723-8735.
16. Rulifson I.C., Karnik S.K., Heiser P.W., et al. Wnt signaling regulates pancreatic beta cell proliferation. Proc Natl Acad Sci U S A 2007, 104:6247-6252.
17. Yi F., Sun J., Lim G.E., Fantus I.G., Brubaker P.L., Jin T. Crosstalk between the insulin and Wnt signaling pathways: evidence from intestinal endocrine L cells. Endocrinology 2008, 149:2341-2351.
18. Christodoulides C., Scarda A., Granzotto M., Milan G., Dalla Nora E., Keogh J., et al. WNT10B mutations in human obesity. Diabetologia 2006, 49:678-684.
19. Kazanskaya O., Glinka A., del Barco Barrantes I., Stannek P., Niehrs C., Wu W. R-Spondin2 is a secreted activator of Wnt/beta-catenin signaling and is required for Xenopus myogenesis. Dev Cell 2004, 7:525-534.
20. Grant S.F., Thorleifsson G., Reynisdottir I., Benediktsson R., Manolescu A., Sainz J., et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006, 38:320-323.
21. Tong Y., Lin Y., Zhang Y., Yang J., Zhang Y., Liu H., et al. Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. BMC Med Genet 2009, 10:15.
22. Savic D., Ye H., Aneas I., Park S.Y., Bell G.I., Nobrega M.A. Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism. Genome Res 2011, 21:1417-1425.
23. Weedon MN The importance of TCF7L2. Diabet Med 2007, 24:1062-1066.
24. Elbein SC Evaluation of polymorphisms known to contribute to risk for diabetes in African and African-American populations. Curr Opin Clin Nutr Metab Care 2007, 10:415-419.
25. Mani A., Radhakrishnan J., Wang H., et al. LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 2007, 315:1278-1282.
26. Kokubu C., Heinzmann U., Kokubu T., et al. Skeletal defects in ringelschwanz mutant mice reveal that Lrp6 is required for proper somitogenesis and osteogenesis. Development 2004, 131:5469-5480.
27. Kanazawa A., Tsukada S., Sekine A., et al. Association of the gene encoding wingless-type mammary tumor virus integrationsite family member 5B (WNT5B) with type 2 diabetes. Am J Hum Genet 2004, 75:832-843.
28. Losick V.P., Morris L.X., Fox D.T., Spradling A. Drosophila stem cell niches: a decade of discovery suggests a unified view of stem cell regulation. Dev Cell 2011, 21:159-171.
29. Ross S.E., Hemati N., Longo K.A., Bennett C.N., Lucas P.C., Erickson R.L., et al. Inhibition of adipogenesis by Wnt signaling. Science 2000, 289(5481):950-953.
30. Boland G.M., Perkins G., Hall D.J., Tuan R.S. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem 2004, 93(6):1210-1230.
31. Vija L., Farge D., Gautier J.F., Vexiau P., Dumitrache C., Bourgarit A., et al. Mesenchymal stem cells: stem cell therapy perspectives for type 1 diabetes. Diabetes Metab 2009, 35:85-93.
32. Chao K.C., Chao K.F., Fu Y.S., Liu S.H. Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes. PLoS ONE 2008, 3:e1451.